-
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 21/01/26 )
NAV
₹28.89
Last change
₹-0.12 -0.0%
Fund Size (AUM)
1310.50 Cr
Performance
13.93% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl
as of 21/01/26
AUM
1310.50 Cr
Expense Ratio
2.1 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K018A5
Fund Manager
Rajat Srivastava
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Rnvstmnt of Inc Dist cum Cap Wdrl | -3.32% | 20.38% | 13.93% |
| Nifty Pharma TR INR | -3.26% | 23.89% | 15.1% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
7.88% |
Max Healthcare Institute Ltd Ordinary Shares |
5.87% |
Abbott India Ltd |
5.48% |
Divi's Laboratories Ltd |
5.01% |
HealthCare Global Enterprises Ltd |
4.84% |
Apollo Hospitals Enterprise Ltd |
4.76% |
Cipla Ltd |
4.14% |
Rainbow Childrens Medicare Ltd |
3.77% |
Ipca Laboratories Ltd |
3.72% |
J.B. Chemicals & Pharmaceuticals Ltd |
3.52% |
Sector Allocation
Healthcare |
96.27% |
Basic Materials |
3.73% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
16.16% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
15.5% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
13.6% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
13.6% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
13.89% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
14.98% (5Y)
-
